XML 25 R2.htm IDEA: XBRL DOCUMENT
v3.25.2

Pay vs Performance Disclosure - USD ($) | 3 Months Ended | 9 Months Ended | 12 Months Ended
--- | --- | --- | ---
Mar. 31, 2025 | Jan. 06, 2025 | Mar. 31, 2025 | Mar. 31, 2024 | Mar. 31, 2023 | Mar. 31, 2022 | Mar. 31, 2021
Pay vs Performance Disclosure |  |  |  |  |  |  |
Pay vs Performance Disclosure, Table |  |  | Pay Versus Performance Table The following table sets forth information concerning: (i) the compensation of our current CEO (Mr. Mongeau) our former CEO (Mr. Klein) and the average compensation for our other NEOs, both as reported in the Summary Compensation Table and with certain adjustments to reflect the “compensation actually paid” ​(“CAP”) to such individuals, as defined under SEC rules, for each of Fiscal 2021, fiscal year ended March 31, 2022 (“Fiscal 2022”), Fiscal 2023, Fiscal 2024 and Fiscal 2025; and (ii) our cumulative total shareholder return, (“TSR”), the cumulative TSR of our peer group (“Peer Group TSR”), net income and Adjusted EBITDA (as defined below) over such years in accordance with SEC rules for each such fiscal year:
​ | ​ | ​ | ​ | Mr. Mongeau(1)(2) | ​ | ​ | Mr. Klein(1)(2) | ​ | ​ | Non-CEO NEOs(1)(2) | ​ | ​ | Value of Initial Fixed $100 Investment Based on: | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | Fiscal Year | ​ | ​ | Summary Compensation Table Total for PEO 1 | ​ | ​ | Compensation Actually Paid to PEO 1 | ​ | ​ | Summary Compensation Table Total for PEO 2 | ​ | ​ | Compensation Actually Paid to PEO 2 | ​ | ​ | Average Summary Compensation Table Total for Non-CEO NEOs(1)(2) | ​ | ​ | Average Compensation Actually Paid to Non-CEO NEOs | ​ | ​ | Total Shareholder Return | ​ | ​ | Horizons Marijuana Life Sciences Index(3) | ​ | ​ | Net Income (millions) | ​ | ​ | Adjusted EBITDA (millions) | ​
​ | 2025 | ​ | ​ | $968,925 | ​ | ​ | $561,392 | ​ | ​ | $5,008,368 | ​ | ​ | ($5,604,577) | ​ | ​ | $1,883,454 | ​ | ​ | $29,307 | ​ | ​ | $0.65 | ​ | ​ | $23.85 | ​ | ​ | ($416) | ​ | ​ | ($16) | ​
​ | 2024 | ​ | ​ | N/A | ​ | ​ | N/A | ​ | ​ | 7,605,091 | ​ | ​ | $11,213,347.01 | ​ | ​ | 1,998,334 | ​ | ​ | $2,866,607 | ​ | ​ | $5.70 | ​ | ​ | $50.79 | ​ | ​ | ($486) | ​ | ​ | ($44) | ​
​ | 2023 | ​ | ​ | N/A | ​ | ​ | N/A | ​ | ​ | $6,459,521 | ​ | ​ | $534,348 | ​ | ​ | $2,339,473 | ​ | ​ | $1,027,156 | ​ | ​ | $11.58 | ​ | ​ | $47.60 | ​ | ​ | ($2,423) | ​ | ​ | ($264) | ​
​ | 2022 | ​ | ​ | N/A | ​ | ​ | N/A | ​ | ​ | $4,541,890 | ​ | ​ | ($27,899,503) | ​ | ​ | $1,977,580 | ​ | ​ | ($1,451,048) | ​ | ​ | $46.33 | ​ | ​ | $101.40 | ​ | ​ | ($248) | ​ | ​ | ($331) | ​
​ | 2021 | ​ | ​ | N/A | ​ | ​ | N/A | ​ | ​ | $2,793,688 | ​ | ​ | $36,054,196 | ​ | ​ | $1,414,433 | ​ | ​ | $4,135,724 | ​ | ​ | $197.26 | ​ | ​ | $214.49 | ​ | ​ | ($1,387) | ​ | ​ | ($258) | ​
Notes: (1) The following individuals are our other NEOs for each fiscal year: ​
​ | ​ | Fiscal Year | ​ | ​ | ​ | CEO(s) | ​ | ​ | ​ | Non-CEO NEOs | ​ | ​
​ | ​ | 2025 | ​ | ​ | ​ | Luc Mongeau(1) and David Klein(2) | ​ | ​ | ​ | Judy Hong(3) and Christelle Gedeon | ​ | ​
​ | ​ | 2024 | ​ | ​ | ​ | David Klein | ​ | ​ | ​ | Judy Hong and Christelle Gedeon | ​ | ​
​ | ​ | 2023 | ​ | ​ | ​ | David Klein | ​ | ​ | ​ | Judy Hong, Christelle Gedeon, and Julious Grant(4) | ​ | ​
​ | ​ | 2022 | ​ | ​ | ​ | David Klein | ​ | ​ | ​ | Judy Hong, Julious Grant(4), Michael Lee(5), Rade Kovacevic(6), and Phillip Shaer(7) | ​ | ​
​ | ​ | 2021 | ​ | ​ | ​ | David Klein | ​ | ​ | ​ | Julious Grant, Michael Lee, Rade Kovacevic, and Phillip Shaer | ​ | ​
​ (1) Mr. Mongeau assumed the role of Chief Executive Officer effective January 6, 2025. ​ (2) Mr. Klein served as CEO through January 6, 2025, at which time Mr. Klein transitioned into the title of Special Advisor to the Board. ​ (3) Ms. Hong’s employment with the Company was terminated effective July 9, 2025. ​ (4) Julious Grant’s engagement with the Company was terminated effective December 16, 2022. ​ (5) Michael Lee stepped down from his role as an executive officer of the Company effective November 18, 2021. ​ (6) Rade Kovacevic stepped down from his role as an executive officer of the Company effective November 18, 2021. ​ (7) Phillip Shaer resigned effective October 1, 2021. ​ (2) Compensation actually paid to our NEOs represents the “Total” compensation reported in the Summary Compensation Table for the applicable fiscal year, adjusted as follows:
​ | ​ | ​ | ​ | ​ | ​ | 2021 | ​ | ​ | ​ | 2022 | ​ | ​ | ​ | 2023 | ​ | ​ | ​ | 2024 | ​ | ​ | ​ | 2025 | ​ | ​
​ | ​ | Adjustments(1) | ​ | ​ | ​ | Mr. Klein | ​ | ​ | ​ | Average non-CEO NEOs | ​ | ​ | ​ | Mr. Klein | ​ | ​ | ​ | Average non-CEO NEOs | ​ | ​ | ​ | Mr. Klein | ​ | ​ | ​ | Average non-CEO NEOs | ​ | ​ | ​ | Mr. Klein | ​ | ​ | ​ | Average non-CEO NEOs | ​ | ​ | ​ | Mr. Mongeau | ​ | ​ | ​ | Mr. Klein | ​ | ​ | ​ | Average non-CEO NEOs | ​ | ​
​ | ​ | Deduction for Amounts Reported under the “Stock Awards” and “Option Awards” Columns in the Summary Compensation Table for Applicable Fiscal Year (“FY”) | ​ | ​ | ​ | $0 | ​ | ​ | ​ | ($627,166) | ​ | ​ | ​ | ($3,467,190) | ​ | ​ | ​ | ($1,083,663) | ​ | ​ | ​ | ($4,702,260) | ​ | ​ | ​ | ($1,510,820) | ​ | ​ | ​ | ($4,606,640) | ​ | ​ | ​ | ($1,125,326) | ​ | ​ | ​ | ($543,989) | ​ | ​ | ​ | ($3,341,776) | ​ | ​ | ​ | ($980,065) | ​ | ​
​ | ​ | Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY that Remain Unvested as of Applicable FY End, determined as of Applicable FY End | ​ | ​ | ​ | $0 | ​ | ​ | ​ | $817,631 | ​ | ​ | ​ | $578,926 | ​ | ​ | ​ | $96,030 | ​ | ​ | ​ | $1,787,971 | ​ | ​ | ​ | $387,207 | ​ | ​ | ​ | $9,410,250 | ​ | ​ | ​ | $2,312,397 | ​ | ​ | ​ | $136,456 | ​ | ​ | ​ | $285,462 | ​ | ​ | ​ | $48,729 | ​ | ​
​ | ​ | Increase/deduction for Awards Granted during any Prior FY that were Outstanding and Unvested as of Applicable FY End, determined based on change in ASC 718 Fair Value from Prior FY End to Applicable FY End | ​ | ​ | ​ | $21,093,560 | ​ | ​ | ​ | $1,540,464 | ​ | ​ | ​ | ($27,451,477) | ​ | ​ | ​ | ($357,364) | ​ | ​ | ​ | ($2,355,067) | ​ | ​ | ​ | ($45,368) | ​ | ​ | ​ | ($842,525) | ​ | ​ | ​ | ($219,638) | ​ | ​ | ​ | $0 | ​ | ​ | ​ | ($6,357,299) | ​ | ​ | ​ | ($779,520) | ​ | ​
​ | ​ | Increase/deduction for Awards Granted during any Prior FY that Vested During Applicable FY, determined based on change in ASC 718 Fair Value from Prior FY End to Vesting Date | ​ | ​ | ​ | $12,166,947 | ​ | ​ | ​ | $990,361 | ​ | ​ | ​ | ($2,101,652) | ​ | ​ | ​ | ($807,142) | ​ | ​ | ​ | ($655,817) | ​ | ​ | ​ | $5,999 | ​ | ​ | ​ | ($273,748) | ​ | ​ | ​ | ($80,324) | ​ | ​ | ​ | $0 | ​ | ​ | ​ | ($1,169,585) | ​ | ​ | ​ | ($140,589) | ​ | ​
​ | ​ | Deduction of ASC 718 Fair Value of Awards Granted during any Prior FY that were Forfeited during Applicable FY, determined as of Prior FY End | ​ | ​ | ​ | $0 | ​ | ​ | ​ | $0 | ​ | ​ | ​ | $0 | ​ | ​ | ​ | ($1,276,489) | ​ | ​ | ​ | $0 | ​ | ​ | ​ | ($149,335) | ​ | ​ | ​ | ($79,081) | ​ | ​ | ​ | ($18,837) | ​ | ​ | ​ | $0 | ​ | ​ | ​ | ($29,746) | ​ | ​ | ​ | ($2,702) | ​ | ​
​ | ​ | TOTAL ADJUSTMENTS | ​ | ​ | ​ | $33,260,508 | ​ | ​ | ​ | $2,721,291 | ​ | ​ | ​ | ($32,441,393) | ​ | ​ | ​ | ($3,428,628) | ​ | ​ | ​ | ($5,925,173) | ​ | ​ | ​ | ($1,312,318) | ​ | ​ | ​ | $3,608,256 | ​ | ​ | ​ | $868,273 | ​ | ​ | ​ | ($407,533) | ​ | ​ | ​ | ($10,612,945) | ​ | ​ | ​ | ($1,854,147) | ​ | ​
​ (1) All adjustments and valuations are based on US$ – equivalent values from C$ at date of valuation throughout Compensation Actually Paid calculations using the applicable conversion rate published by Bloomberg. ​ (3) TSR is cumulative for the measurement periods beginning on March 31, 2021 and ending on March 31 of each of 2025, 2024, 2023 2022 and 2021, respectively, calculated in accordance with Item 201(e) of Regulation S-K. Table has been updated to reflect Horizons Marijuana Life Sciences Index, which is the same index used in our performance graph in the Company’s Annual Reports on Form 10-K for the year ended March 31, 2024. ​ (4) Adjusted EBITDA is a non-GAAP financial measure. Adjusted EBITDA is calculated as the reported net loss, adjusted to exclude income tax recovery (expense); other income (expense), net; loss on equity method investments; share-based compensation expense; depreciation and amortization expense; asset impairment and restructuring costs; and charges related to the flow-through of inventory step-up on business combinations, and further adjusted to remove acquisition-related costs. |  |  |  |
Company Selected Measure Name |  |  | Adjusted EBITDA |  |  |  |
Named Executive Officers, Footnote |  |  | (1) The following individuals are our other NEOs for each fiscal year:
​ | ​ | Fiscal Year | ​ | ​ | ​ | CEO(s) | ​ | ​ | ​ | Non-CEO NEOs | ​ | ​
​ | ​ | 2025 | ​ | ​ | ​ | Luc Mongeau(1) and David Klein(2) | ​ | ​ | ​ | Judy Hong(3) and Christelle Gedeon | ​ | ​
​ | ​ | 2024 | ​ | ​ | ​ | David Klein | ​ | ​ | ​ | Judy Hong and Christelle Gedeon | ​ | ​
​ | ​ | 2023 | ​ | ​ | ​ | David Klein | ​ | ​ | ​ | Judy Hong, Christelle Gedeon, and Julious Grant(4) | ​ | ​
​ | ​ | 2022 | ​ | ​ | ​ | David Klein | ​ | ​ | ​ | Judy Hong, Julious Grant(4), Michael Lee(5), Rade Kovacevic(6), and Phillip Shaer(7) | ​ | ​
​ | ​ | 2021 | ​ | ​ | ​ | David Klein | ​ | ​ | ​ | Julious Grant, Michael Lee, Rade Kovacevic, and Phillip Shaer | ​ | ​
(1) Mr. Mongeau assumed the role of Chief Executive Officer effective January 6, 2025. (2) Mr. Klein served as CEO through January 6, 2025, at which time Mr. Klein transitioned into the title of Special Advisor to the Board. (3) Ms. Hong’s employment with the Company was terminated effective July 9, 2025. (4) Julious Grant’s engagement with the Company was terminated effective December 16, 2022. (5) Michael Lee stepped down from his role as an executive officer of the Company effective November 18, 2021. (6) Rade Kovacevic stepped down from his role as an executive officer of the Company effective November 18, 2021. (7) Phillip Shaer resigned effective October 1, 2021. |  |  |  |
Peer Group Issuers, Footnote |  |  | (3) TSR is cumulative for the measurement periods beginning on March 31, 2021 and ending on March 31 of each of 2025, 2024, 2023 2022 and 2021, respectively, calculated in accordance with Item 201(e) of Regulation S-K. Table has been updated to reflect Horizons Marijuana Life Sciences Index, which is the same index used in our performance graph in the Company’s Annual Reports on Form 10-K for the year ended March 31, 2024. |  |  |  |
Adjustment To PEO Compensation, Footnote |  |  | (2) Compensation actually paid to our NEOs represents the “Total” compensation reported in the Summary Compensation Table for the applicable fiscal year, adjusted as follows:
​ | ​ | ​ | ​ | ​ | ​ | 2021 | ​ | ​ | ​ | 2022 | ​ | ​ | ​ | 2023 | ​ | ​ | ​ | 2024 | ​ | ​ | ​ | 2025 | ​ | ​
​ | ​ | Adjustments(1) | ​ | ​ | ​ | Mr. Klein | ​ | ​ | ​ | Average non-CEO NEOs | ​ | ​ | ​ | Mr. Klein | ​ | ​ | ​ | Average non-CEO NEOs | ​ | ​ | ​ | Mr. Klein | ​ | ​ | ​ | Average non-CEO NEOs | ​ | ​ | ​ | Mr. Klein | ​ | ​ | ​ | Average non-CEO NEOs | ​ | ​ | ​ | Mr. Mongeau | ​ | ​ | ​ | Mr. Klein | ​ | ​ | ​ | Average non-CEO NEOs | ​ | ​
​ | ​ | Deduction for Amounts Reported under the “Stock Awards” and “Option Awards” Columns in the Summary Compensation Table for Applicable Fiscal Year (“FY”) | ​ | ​ | ​ | $0 | ​ | ​ | ​ | ($627,166) | ​ | ​ | ​ | ($3,467,190) | ​ | ​ | ​ | ($1,083,663) | ​ | ​ | ​ | ($4,702,260) | ​ | ​ | ​ | ($1,510,820) | ​ | ​ | ​ | ($4,606,640) | ​ | ​ | ​ | ($1,125,326) | ​ | ​ | ​ | ($543,989) | ​ | ​ | ​ | ($3,341,776) | ​ | ​ | ​ | ($980,065) | ​ | ​
​ | ​ | Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY that Remain Unvested as of Applicable FY End, determined as of Applicable FY End | ​ | ​ | ​ | $0 | ​ | ​ | ​ | $817,631 | ​ | ​ | ​ | $578,926 | ​ | ​ | ​ | $96,030 | ​ | ​ | ​ | $1,787,971 | ​ | ​ | ​ | $387,207 | ​ | ​ | ​ | $9,410,250 | ​ | ​ | ​ | $2,312,397 | ​ | ​ | ​ | $136,456 | ​ | ​ | ​ | $285,462 | ​ | ​ | ​ | $48,729 | ​ | ​
​ | ​ | Increase/deduction for Awards Granted during any Prior FY that were Outstanding and Unvested as of Applicable FY End, determined based on change in ASC 718 Fair Value from Prior FY End to Applicable FY End | ​ | ​ | ​ | $21,093,560 | ​ | ​ | ​ | $1,540,464 | ​ | ​ | ​ | ($27,451,477) | ​ | ​ | ​ | ($357,364) | ​ | ​ | ​ | ($2,355,067) | ​ | ​ | ​ | ($45,368) | ​ | ​ | ​ | ($842,525) | ​ | ​ | ​ | ($219,638) | ​ | ​ | ​ | $0 | ​ | ​ | ​ | ($6,357,299) | ​ | ​ | ​ | ($779,520) | ​ | ​
​ | ​ | Increase/deduction for Awards Granted during any Prior FY that Vested During Applicable FY, determined based on change in ASC 718 Fair Value from Prior FY End to Vesting Date | ​ | ​ | ​ | $12,166,947 | ​ | ​ | ​ | $990,361 | ​ | ​ | ​ | ($2,101,652) | ​ | ​ | ​ | ($807,142) | ​ | ​ | ​ | ($655,817) | ​ | ​ | ​ | $5,999 | ​ | ​ | ​ | ($273,748) | ​ | ​ | ​ | ($80,324) | ​ | ​ | ​ | $0 | ​ | ​ | ​ | ($1,169,585) | ​ | ​ | ​ | ($140,589) | ​ | ​
​ | ​ | Deduction of ASC 718 Fair Value of Awards Granted during any Prior FY that were Forfeited during Applicable FY, determined as of Prior FY End | ​ | ​ | ​ | $0 | ​ | ​ | ​ | $0 | ​ | ​ | ​ | $0 | ​ | ​ | ​ | ($1,276,489) | ​ | ​ | ​ | $0 | ​ | ​ | ​ | ($149,335) | ​ | ​ | ​ | ($79,081) | ​ | ​ | ​ | ($18,837) | ​ | ​ | ​ | $0 | ​ | ​ | ​ | ($29,746) | ​ | ​ | ​ | ($2,702) | ​ | ​
​ | ​ | TOTAL ADJUSTMENTS | ​ | ​ | ​ | $33,260,508 | ​ | ​ | ​ | $2,721,291 | ​ | ​ | ​ | ($32,441,393) | ​ | ​ | ​ | ($3,428,628) | ​ | ​ | ​ | ($5,925,173) | ​ | ​ | ​ | ($1,312,318) | ​ | ​ | ​ | $3,608,256 | ​ | ​ | ​ | $868,273 | ​ | ​ | ​ | ($407,533) | ​ | ​ | ​ | ($10,612,945) | ​ | ​ | ​ | ($1,854,147) | ​ | ​
(1) All adjustments and valuations are based on US$ – equivalent values from C$ at date of valuation throughout Compensation Actually Paid calculations using the applicable conversion rate published by Bloomberg. |  |  |  |
Non-PEO NEO Average Total Compensation Amount |  |  | $ 1,883,454 | $ 1,998,334 | $ 2,339,473 | $ 1,977,580 | $ 1,414,433
Non-PEO NEO Average Compensation Actually Paid Amount |  |  | $ 29,307 | 2,866,607 | 1,027,156 | (1,451,048) | 4,135,724
Adjustment to Non-PEO NEO Compensation Footnote |  |  | (2) Compensation actually paid to our NEOs represents the “Total” compensation reported in the Summary Compensation Table for the applicable fiscal year, adjusted as follows:
​ | ​ | ​ | ​ | ​ | ​ | 2021 | ​ | ​ | ​ | 2022 | ​ | ​ | ​ | 2023 | ​ | ​ | ​ | 2024 | ​ | ​ | ​ | 2025 | ​ | ​
​ | ​ | Adjustments(1) | ​ | ​ | ​ | Mr. Klein | ​ | ​ | ​ | Average non-CEO NEOs | ​ | ​ | ​ | Mr. Klein | ​ | ​ | ​ | Average non-CEO NEOs | ​ | ​ | ​ | Mr. Klein | ​ | ​ | ​ | Average non-CEO NEOs | ​ | ​ | ​ | Mr. Klein | ​ | ​ | ​ | Average non-CEO NEOs | ​ | ​ | ​ | Mr. Mongeau | ​ | ​ | ​ | Mr. Klein | ​ | ​ | ​ | Average non-CEO NEOs | ​ | ​
​ | ​ | Deduction for Amounts Reported under the “Stock Awards” and “Option Awards” Columns in the Summary Compensation Table for Applicable Fiscal Year (“FY”) | ​ | ​ | ​ | $0 | ​ | ​ | ​ | ($627,166) | ​ | ​ | ​ | ($3,467,190) | ​ | ​ | ​ | ($1,083,663) | ​ | ​ | ​ | ($4,702,260) | ​ | ​ | ​ | ($1,510,820) | ​ | ​ | ​ | ($4,606,640) | ​ | ​ | ​ | ($1,125,326) | ​ | ​ | ​ | ($543,989) | ​ | ​ | ​ | ($3,341,776) | ​ | ​ | ​ | ($980,065) | ​ | ​
​ | ​ | Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY that Remain Unvested as of Applicable FY End, determined as of Applicable FY End | ​ | ​ | ​ | $0 | ​ | ​ | ​ | $817,631 | ​ | ​ | ​ | $578,926 | ​ | ​ | ​ | $96,030 | ​ | ​ | ​ | $1,787,971 | ​ | ​ | ​ | $387,207 | ​ | ​ | ​ | $9,410,250 | ​ | ​ | ​ | $2,312,397 | ​ | ​ | ​ | $136,456 | ​ | ​ | ​ | $285,462 | ​ | ​ | ​ | $48,729 | ​ | ​
​ | ​ | Increase/deduction for Awards Granted during any Prior FY that were Outstanding and Unvested as of Applicable FY End, determined based on change in ASC 718 Fair Value from Prior FY End to Applicable FY End | ​ | ​ | ​ | $21,093,560 | ​ | ​ | ​ | $1,540,464 | ​ | ​ | ​ | ($27,451,477) | ​ | ​ | ​ | ($357,364) | ​ | ​ | ​ | ($2,355,067) | ​ | ​ | ​ | ($45,368) | ​ | ​ | ​ | ($842,525) | ​ | ​ | ​ | ($219,638) | ​ | ​ | ​ | $0 | ​ | ​ | ​ | ($6,357,299) | ​ | ​ | ​ | ($779,520) | ​ | ​
​ | ​ | Increase/deduction for Awards Granted during any Prior FY that Vested During Applicable FY, determined based on change in ASC 718 Fair Value from Prior FY End to Vesting Date | ​ | ​ | ​ | $12,166,947 | ​ | ​ | ​ | $990,361 | ​ | ​ | ​ | ($2,101,652) | ​ | ​ | ​ | ($807,142) | ​ | ​ | ​ | ($655,817) | ​ | ​ | ​ | $5,999 | ​ | ​ | ​ | ($273,748) | ​ | ​ | ​ | ($80,324) | ​ | ​ | ​ | $0 | ​ | ​ | ​ | ($1,169,585) | ​ | ​ | ​ | ($140,589) | ​ | ​
​ | ​ | Deduction of ASC 718 Fair Value of Awards Granted during any Prior FY that were Forfeited during Applicable FY, determined as of Prior FY End | ​ | ​ | ​ | $0 | ​ | ​ | ​ | $0 | ​ | ​ | ​ | $0 | ​ | ​ | ​ | ($1,276,489) | ​ | ​ | ​ | $0 | ​ | ​ | ​ | ($149,335) | ​ | ​ | ​ | ($79,081) | ​ | ​ | ​ | ($18,837) | ​ | ​ | ​ | $0 | ​ | ​ | ​ | ($29,746) | ​ | ​ | ​ | ($2,702) | ​ | ​
​ | ​ | TOTAL ADJUSTMENTS | ​ | ​ | ​ | $33,260,508 | ​ | ​ | ​ | $2,721,291 | ​ | ​ | ​ | ($32,441,393) | ​ | ​ | ​ | ($3,428,628) | ​ | ​ | ​ | ($5,925,173) | ​ | ​ | ​ | ($1,312,318) | ​ | ​ | ​ | $3,608,256 | ​ | ​ | ​ | $868,273 | ​ | ​ | ​ | ($407,533) | ​ | ​ | ​ | ($10,612,945) | ​ | ​ | ​ | ($1,854,147) | ​ | ​
(1) All adjustments and valuations are based on US$ – equivalent values from C$ at date of valuation throughout Compensation Actually Paid calculations using the applicable conversion rate published by Bloomberg. |  |  |  |
Compensation Actually Paid vs. Total Shareholder Return |  |  |  |  |  |  |
Compensation Actually Paid vs. Net Income |  |  |  |  |  |  |
Compensation Actually Paid vs. Company Selected Measure |  |  |  |  |  |  |
Total Shareholder Return Vs Peer Group |  |  |  |  |  |  |
Tabular List, Table |  |  | Pay Versus Performance Tabular List The following performance measures represent the most important financial performance measures used by us to link compensation actually paid to our NEOs to performance for Fiscal 2025: • Adjusted EBITDA; Net revenue; Individual objectives; and Relative TSR. |  |  |  |
Total Shareholder Return Amount |  |  | $ 0.65 | 5.7 | 11.58 | 46.33 | 197.26
Peer Group Total Shareholder Return Amount |  |  | 23.85 | 50.79 | 47.6 | 101.4 | 214.49
Net Income (Loss) |  |  | $ (416,000,000) | $ (486,000,000) | $ (2,423,000,000) | $ (248,000,000) | $ (1,387,000,000)
Company Selected Measure Amount |  |  | (16,000,000) | (44,000,000) | (264,000,000) | (331,000,000) | (258,000,000)
PEO Name | Luc Mongeau | David Klein |  |  |  |  |
Measure:: 1 |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Name |  |  | Adjusted EBITDA |  |  |  |
Non-GAAP Measure Description |  |  | (4) Adjusted EBITDA is a non-GAAP financial measure. Adjusted EBITDA is calculated as the reported net loss, adjusted to exclude income tax recovery (expense); other income (expense), net; loss on equity method investments; share-based compensation expense; depreciation and amortization expense; asset impairment and restructuring costs; and charges related to the flow-through of inventory step-up on business combinations, and further adjusted to remove acquisition-related costs. |  |  |  |
Measure:: 2 |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Name |  |  | Net revenue |  |  |  |
Measure:: 3 |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Name |  |  | Individual objectives |  |  |  |
Measure:: 4 |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Name |  |  | Relative TSR |  |  |  |
Mr. Mongeau [Member] |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
PEO Total Compensation Amount |  |  | $ 968,925 |  |  |  |
PEO Actually Paid Compensation Amount |  |  | 561,392 |  |  |  |
Mr. Klein [Member] |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
PEO Total Compensation Amount |  |  | 5,008,368 | $ 7,605,091 | $ 6,459,521 | $ 4,541,890 | $ 2,793,688
PEO Actually Paid Compensation Amount |  |  | (5,604,577) | 11,213,347.01 | 534,348 | (27,899,503) | 36,054,196
PEO | Mr. Mongeau [Member] | Equity Awards Adjustments |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | (407,533) |  |  |  |
PEO | Mr. Mongeau [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | (543,989) |  |  |  |
PEO | Mr. Mongeau [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | 136,456 |  |  |  |
PEO | Mr. Mongeau [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | 0 |  |  |  |
PEO | Mr. Mongeau [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | 0 |  |  |  |
PEO | Mr. Mongeau [Member] | Equity Awards Adjustments Change In Fair Value Of Awards Granted In Prior Years Forfeited During Current Year [Member] |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | 0 |  |  |  |
PEO | Mr. Klein [Member] | Equity Awards Adjustments |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | (10,612,945) | 3,608,256 | (5,925,173) | (32,441,393) | 33,260,508
PEO | Mr. Klein [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | (3,341,776) | (4,606,640) | (4,702,260) | (3,467,190) | 0
PEO | Mr. Klein [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | 285,462 | 9,410,250 | 1,787,971 | 578,926 | 0
PEO | Mr. Klein [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | (6,357,299) | (842,525) | (2,355,067) | (27,451,477) | 21,093,560
PEO | Mr. Klein [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | (1,169,585) | (273,748) | (655,817) | (2,101,652) | 12,166,947
PEO | Mr. Klein [Member] | Equity Awards Adjustments Change In Fair Value Of Awards Granted In Prior Years Forfeited During Current Year [Member] |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | (29,746) | (79,081) | 0 | 0 | 0
Non-PEO NEO | Equity Awards Adjustments |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | (1,854,147) | 868,273 | (1,312,318) | (3,428,628) | 2,721,291
Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | (980,065) | (1,125,326) | (1,510,820) | (1,083,663) | (627,166)
Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | 48,729 | 2,312,397 | 387,207 | 96,030 | 817,631
Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | (779,520) | (219,638) | (45,368) | (357,364) | 1,540,464
Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | (140,589) | (80,324) | 5,999 | (807,142) | 990,361
Non-PEO NEO | Equity Awards Adjustments Change In Fair Value Of Awards Granted In Prior Years Forfeited During Current Year [Member] |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | $ (2,702) | $ (18,837) | $ (149,335) | $ (1,276,489) | $ 0

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToNonPeoNeoCompFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToPeoCompFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_CoSelectedMeasureAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_CoSelectedMeasureName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph iii + Details
Name: | ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph ii + Details
Name: | ecd_CompActuallyPaidVsNetIncomeTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph i + Details
Name: | ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_MeasureName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_NamedExecutiveOfficersFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_NonGaapMeasureDescriptionTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iii + Details
Name: | ecd_NonPeoNeoAvgCompActuallyPaidAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph ii + Details
Name: | ecd_NonPeoNeoAvgTotalCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_PeerGroupIssuersFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_PeerGroupTotalShareholderRtnAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iii + Details
Name: | ecd_PeoActuallyPaidCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_PeoName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph ii + Details
Name: | ecd_PeoTotalCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 1 + Details
Name: | ecd_PvpTable
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 1 + Details
Name: | ecd_PvpTableTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 6 + Details
Name: | ecd_TabularListTableTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_TotalShareholderRtnAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph iv + Details
Name: | ecd_TotalShareholderRtnVsPeerGroupTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 60 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 323 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (g)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(20)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4 Reference 17: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section 45 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(18)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(9)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1 Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(1)(d)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 31: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 32: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 60B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B Reference 33: http://www.xbrl.org/2003/role/disclosureRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7 Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28 Reference 35: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A Reference 36: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(22)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1 + Details
Name: | us-gaap_NetIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | ecd_MeasureAxis=1
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=2
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=3
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=4
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=cgc_MrMongeauMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=cgc_MrKleinMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_ExecutiveCategoryAxis=ecd_PeoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_EqtyAwrdsAdjsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=cgc_FairValueOfAwardsGrantedDuringAnyPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |